Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: cancer and inflammation therapeutics - Xcovery

Next Previous
Search
Drug Profile

Research programme: cancer and inflammation therapeutics - Xcovery

Alternative Names: X-339; X-376; X-379; X-414; X-480

Latest Information Update: 28 Oct 2018

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Xcovery
  • Developer Xcovery Holdings
  • Class Pyrazolones; Pyrimidines; Small molecules
  • Mechanism of Action 1 Phosphatidylinositol 3 kinase inhibitors; Hepatocyte growth factor inhibitors; MTOR protein inhibitors; P38 mitogen-activated protein kinase inhibitors; Vascular endothelial growth factor receptor-1 antagonists; Vascular endothelial growth factor receptor-2 antagonists; Vascular endothelial growth factor receptor-3 antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes - Cancer

Highest Development Phases

  • No development reported Cancer
  • Discontinued Inflammation

Most Recent Events

  • 28 Oct 2018 No recent reports of development identified for preclinical development in Cancer in USA (PO)
  • 05 Oct 2016 Discontinued for Inflammation in USA (PO)
  • 05 Oct 2016 Preclinical development is ongoing for cancer in USA (Xcovery pipeline, October 2016)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top